Oral Anticoagulation and Self-management

Sponsor
Osakidetza (Other)
Overall Status
Unknown status
CT.gov ID
NCT01878539
Collaborator
Instituto de Salud Carlos III (Other)
333
1
1
30
11.1

Study Details

Study Description

Brief Summary

An intervention program targeting patients and caregivers based on education about their condition and training in the use of portable coagulomenter to self monitor and training on the treatment adjustment to self manage, can be effective to enable patients in OACs to self manage as well as to identify determinant factors associated with the success and failure of the program.

Condition or Disease Intervention/Treatment Phase
  • Device: coagulometer
  • Behavioral: training programme
N/A

Detailed Description

BACKGROUND: The skills of patients on oral anticoagulants are critical for achieving good outcomes with this treatment. Self-management, or the capacity of patients to control their INR (International Normalized Ratio)level and adjust their treatment, is an effective strategy of treatment. Capacity of patients to self manage is determined by a range of factors. The identification of these factors would improve the design of self management programmes and in turn increase the number of patients able to self-manage. The objective of our study is to identify those factors that determine the ability of patients on oral anticoagulant therapy to achieve self-management of their treatment.

METHOD: This will be a three year quasi- experimental prospective study with a control group. 333 patients on anticoagulant therapy from five health centres of the Basque Health Service are to be followed up for a period of six months each after the intervention, to assess their ability to self-test and self-manage. The intervention will consist of a patient training programme involving the provision of information and practical training concerning their condition and its treatment, as well as how to use a portable blood coagulation monitoring device and adjust their anticoagulant dose.

DISCUSSION: Training programmes for self-management are effective in terms of enabling patients to acquire the necessary skills, though the level of success seems to depend on various patient-related factors. Given the proven benefits of self-management, it would be useful to properly characterise these factors and use this information to successfully increase the percentage of patients on on oral anticoagulants able to self-manage their own treatment.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
333 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Oral Anticoagulation and Self-management: Analysis of the Factors That Determine the Feasibility of Using Self-testing and Self-management in Primary Care
Study Start Date :
Jun 1, 2012
Anticipated Primary Completion Date :
Jun 1, 2013
Anticipated Study Completion Date :
Dec 1, 2014

Arms and Interventions

Arm Intervention/Treatment
Experimental: Health Center training

The intervention will consist of a patient training programme involving the provision of information and practical training concerning their condition and its treatment, as well as how to use a portable blood coagulation monitoring device and adjust their anticoagulant dose.

Device: coagulometer
Other Names:
  • how to use a portable blood coagulation monitoring device and adjust their anticoagulant dose
  • Behavioral: training programme
    Other Names:
  • patient training programme involving the provision of information and practical training concerning their condition and its treatment
  • Outcome Measures

    Primary Outcome Measures

    1. Control of INR (International Normalized Ratio) [6 months]

      So the primary objectives of this study are to assess the ability of patients/caregivers to test INR (International Normalized Ratio) levels with a portable coagulometer and capillary whole blood from a finger prick and the impact of a range of factors on the ability of patients on OACs to self-monitor and self-manage their treatment. If the INR is within the personal range above 80% it will consider a good control

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    16 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Anticuagulated

    • Living in the study area

    Exclusion Criteria:
    • Older than 16 years old

    • More than one year cuagulated

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Osakidetza Donostia-San Sebastian Gipuzkoa Spain 20003

    Sponsors and Collaborators

    • Osakidetza
    • Instituto de Salud Carlos III

    Investigators

    • Principal Investigator: Eduardo Tamayo, Doctor, Osakidetza

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Eduardo Tamayo Aguirre, Family Doctor, Osakidetza
    ClinicalTrials.gov Identifier:
    NCT01878539
    Other Study ID Numbers:
    • ISCIII-11/02285
    First Posted:
    Jun 17, 2013
    Last Update Posted:
    Jun 17, 2013
    Last Verified:
    Jun 1, 2013
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jun 17, 2013